An incredible discovery that could revolutionise cancer treatment was made in March 2024.
The therapeutic experiment, which was used to treat glioblastoma, a deadly kind of brain cancer, showed “dramatic responses within days” for the trial participants.
A novel method to CAR-T therapy, a sophisticated and individualised treatment that triggers your immune system to attack the cancer cells,
is being used by researchers and surgeons from the Mass General Brigham healthcare system. Continues…
Utilising the patient’s own immune system, CAR-T therapy is typically used to treat leukaemia.
Before being returned to the patient and used to treat their ailment, a patient’s blood is usually extracted and sent to a laboratory to be “trained” to combat the cancer cells.
Source: Pexels
In this instance, the researchers and surgeons used an existing CAR-T therapy variation in conjunction with antibodies to treat three patients
with recurrent glioblastoma, and the outcomes were astounding.
Within two days of treatment, one patient’s tumour size shrank by 18.5%, according to a study published in
The New England Journal of Medicine. The tumour shrank by a remarkable 60.7% on day 69.
The Mass General Brigham said that another patient’s “tumour regressed rapidly.”
An MRI performed five days after the third patient’s therapy
